Home › Glioblastoma › Pennsylvania › Philadelphia
Glioblastoma clinical trials in Philadelphia, PA
11 studies for Glioblastoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
RecruitingPhase 2
- Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
RecruitingPhase 1/2
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
RecruitingEarly phase 1
- Hospital of the University of Pennsylvania, Philadelphia
- University of Pennsylvania, Philadelphia
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Children's Hospital of Philadelphia, Philadelphia
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Thomas Jefferson University Hospital, Philadelphia
WBSI Guided Personalized Delivery of TTFields
Recruiting
- Abramson Cancer Center, Philadelphia
- Penn Medicine, University of Pennsylvania, Philadelphia
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Children's Hospital of Philadelphia, Philadelphia
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
RecruitingPhase 1
- Children's Hospital of Philadelphia, Philadelphia
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Children's Hospital of Philadelphia, Philadelphia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Philadelphia
Glioblastoma trials in other cities
- New York City, NY30 studies
- Boston, MA28 studies
- Houston, TX26 studies
- Los Angeles, CA24 studies
- Durham, NC20 studies
- San Francisco, CA17 studies
- Chicago, IL15 studies
- Washington, DC15 studies
- Columbus, OH14 studies
- Miami, FL14 studies
- Rochester, MN13 studies
- Jacksonville, FL13 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Prostate Cancer44 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.